CA60255C8850 - Common Stock
NASDAQ:MNMD (1/30/2023, 8:36:08 AM)0 (0%)
GICS Sector | Health Care | ||
GICS Industry | Pharmaceuticals |
Valuation | Growth | ||
Profitability | Health | ||
Dividend |
Earnings (Last) | 08-11 2022-08-11/amc | Earnings (Next) | 03-27 2023-03-27 |
Ins Owners | 17.97% | Inst Owners | 6.33% |
Market Cap | 96.88M | Shares | 28.16M |
PE | N/A | Fwd PE | N/A |
Dividend Yield | N/A | Analysts | 85.71 |
IPO | 05-04 2015-05-04 |
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm is engaged in developing products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. The firm is developing a pipeline of drug candidates, targeting the serotonin, dopamine and acetylcholine systems. This specifically includes pharmaceutically optimized drug products derived from the psychedelic and empathogen drug classes, including lysergic acid diethylamide (LSD), R(-)-methylenedioxymethamphetamine (MDMA) and zolunicant, or 18-methoxycoronaridine (MC), a congener of ibogaine. The Company’s subsidiaries include Mind Medicine, Inc. (MindMed US), HealthMode, Inc., MindMed Pty Ltd., and MindMed GmbH.
MIND MEDICINE MINDMED INC
1166 Alberni Steet, Suite 1604
Vancouver BRITISH COLUMBIA
P: 12122206633.0
Employees: 50
Website: https://mindmed.co/
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END
/PRNewswire/ -- Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of...
Here you can normally see the latest stock twits on MNMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: